Photo of Roy Jung

Roy Jung is an associate in the Intellectual Property Practice Group in the firm's Washington, D.C. office. Roy’s practice focuses on intellectual property litigation.

In Medytox, Inc. v. Galderma S.A. No. 2022-1165, __ F.4th ____ (Fed. Cir. June 27, 2023), the case addresses: (i) whether Medytox’s proposed substitute claims introduce new matter, and satisfy the written description and enablement requirements and (ii) whether “the Board’s revision of its claim construction [position]. . . made between a preliminary guidance and a final written decision (“FWD”) violates the Administrative Procedure Act (“APA”).”Continue Reading Federal Circuit Weighs in on Whether the PTAB Can Revise its Claim Construction Between Institution and Final Decision

We are excited to share Sheppard Mullin’s inaugural quarterly report on key Federal Circuit decisions. The Spring 2023 Quarterly Report provides summaries of most key patent law-related decisions from January 1, 2023 to March 31, 2023.Continue Reading 2023 Federal Circuit Case Summaries